Fayez Sarofim & Co Portfolio holdings
AUM
$41.7B
This Quarter Return
-5.91%
1 Year Return
+15.12%
3 Year Return
+67.65%
5 Year Return
+130.07%
10 Year Return
+262.45%
AUM
$25.3B
AUM Growth
+$25.3B
(-7.6%)
Cap. Flow
+$300M
Cap. Flow
% of AUM
1.19%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
294
New
5
Increased
64
Reduced
119
Closed
16
Top Buys
| 1 |
Novo Nordisk
NVO
|
$44.9M |
| 2 |
Exxon Mobil
XOM
|
$17.1M |
| 3 |
HES
Hess
HES
|
$13.3M |
| 4 |
Visa
V
|
$11.5M |
| 5 |
EOG Resources
EOG
|
$7.04M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$49.1M |
| 2 |
TotalEnergies
TTE
|
$44.3M |
| 3 |
Kellanova
K
|
$38.6M |
| 4 |
Apple
AAPL
|
$36.4M |
| 5 |
Organon & Co
OGN
|
$26.1M |
Sector Composition
| 1 | Technology | 21.28% |
| 2 | Consumer Staples | 19.28% |
| 3 | Financials | 18.16% |
| 4 | Energy | 12.21% |
| 5 | Healthcare | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Invesco
IVZ
$9.68B
| $146K | ﹤0.01% |
10,691
| – | – |
|
277
Plains GP Holdings
PAGP
$3.71B
| $125K | ﹤0.01% |
11,500
| – | – |
|
|
PLXP
278
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $9K | ﹤0.01% |
13,729
| – | – |
|
|
WWE
279
DELISTED
World Wrestling Entertainment
WWE
| – | – |
-25,070
| Closed | -$1.57M |
|
280
Travelers Companies
TRV
$62.3B
| – | – |
-2,435
| Closed | -$412K |
|
281
Teleflex
TFX
$5.57B
| – | – |
-2,312
| Closed | -$568K |
|
282
Sanofi
SNY
$122B
| – | – |
-11,180
| Closed | -$559K |
|
283
J.M. Smucker
SJM
$12B
| – | – |
-36,624
| Closed | -$4.69M |
|
284
ServiceNow
NOW
$191B
| – | – |
-1,242
| Closed | -$591K |
|
285
3M
MMM
$81B
| – | – |
-30,935
| Closed | -$4M |
|
286
Lamb Weston
LW
$7.88B
| – | – |
-3,024
| Closed | -$216K |
|
287
Leggett & Platt
LEG
$1.28B
| – | – |
-82,236
| Closed | -$2.84M |
|
288
iShares Russell 1000 Growth ETF
IWF
$117B
| – | – |
-5,000
| Closed | -$1.09M |
|
289
HP
HPQ
$26.8B
| – | – |
-7,876
| Closed | -$258K |
|
290
GSK
GSK
$79.3B
| – | – |
-6,964
| Closed | -$303K |
|
291
Energy Transfer Partners
ET
$60.3B
| – | – |
-14,672
| Closed | -$146K |
|
292
Conagra Brands
CAG
$9.19B
| – | – |
-12,676
| Closed | -$434K |
|
293
Bruker
BRKR
$4.45B
| – | – |
-3,290
| Closed | -$206K |
|
294
AstraZeneca
AZN
$255B
| – | – |
-3,345
| Closed | -$221K |
|